Using light to monitor cancer

- EN - FR
The cancer exosome is detected when the light interacts with the silicon nanostr
The cancer exosome is detected when the light interacts with the silicon nanostructures. © Yasaman Jahani / 2021 EPFL
The cancer exosome is detected when the light interacts with the silicon nanostructures. Yasaman Jahani / 2021 EPFL - Researchers at EPFL have developed a technology based on nanophotonics and data science to detect and monitor cancer biomarkers at an early stage. Their research is published. Medical doctors examine body fluids of their patients, such as blood, urine, saliva, or nasal swabs, for diagnostics. This is because substances in such biofluids may provide vital information about one's health state. Biosensors are emerging devices capable of analyzing such biosamples and look for substances indicative of disease. COVID-19 tests are the most current examples of biosensors.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.



Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience